Industry Reports

Bio capacity in Europe is predicted to overtake the USA by 2020 according to the bio findings of CPhI Annual Report released live at bioLIVE in Madrid (9-11, October 2018) – adjacent to CPhI Worldwide. The...

The global ADC therapeutics market is expected to grow to $4bn by 2023, with double digit approvals within 3-years, according to a new analysis in the CPhI Annual Report – the complete findings of which were released live at...

CPhI Worldwide, the world’s largest pharma event – taking place in Madrid (9-11, October 2018) and organized by UBM (part of Informa plc) – releases its annual report analysis of opioid contract services and continuous manufacturing. ...

CPhI Worldwide the world’s largest pharma event – taking place in Madrid October (9-11) and organized by UBM (part of Informa plc) – releases the first part of its 6th Annual Report with a stark warning from Girish Malhotra,...

CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are driving increased growth across the Middle East and North Africa (MENA) pharma market – ageing and gentrifying populations, increased healthcare spending, and a modernising supply...

Genstar Capital, a leading investor in healthcare technology and services companies,is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry. As part of the...

Sovereign Capital Partners, the UK private equity Buy & Build specialist, is pleased to announce the realisation of its investment in Xendo - a leading independent consultancy and project management organisation in the fields of (bio)pharmaceutical products, medical devices...